ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

CRIS Curis Inc

14.47
-0.05 (-0.34%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Curis Inc CRIS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.05 -0.34% 14.47 13:00:04
始値 安値 高値 終値 前日終値
14.44 14.25 14.6899 14.47 14.52
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0520:30PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
2024/4/0420:30PRNUSCuris to Present at Upcoming Healthcare Conferences in April
2024/2/1306:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0906:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/0906:27EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/2/0906:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/0822:01EDGAR2Form 8-K - Current report
2024/2/0822:00PRNUSCuris Provides Fourth Quarter 2023 Business Update
2024/2/0122:00PRNUSCuris to Release Fourth Quarter 2023 Financial Results and..
2024/1/1122:13EDGAR2Form 8-K - Current report
2024/1/0522:00PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
2023/12/2206:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2023/12/1222:00PRNUSCuris Announces Initial Combination Study Data from its..
2023/12/1122:00PRNUSCuris Presented Clinical Data from the TakeAim Leukemia..
2023/12/0622:00PRNUSCuris Announces Three Presentations at ASH
2023/12/0522:00PRNUSCuris Enters into Agreement for Emavusertib / Pembrolizumab..
2023/11/0221:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0221:01EDGAR2Form 8-K - Current report
2023/11/0221:00PRNUSCuris Provides Third Quarter 2023 Business Update
2023/10/2621:30PRNUSCuris to Release Third Quarter 2023 Financial Results and..
2023/10/0621:56PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
2023/9/2905:05EDGAR2Form 8-K/A - Current report: [Amend]
2023/9/2821:54EDGAR2Form 8-K - Current report
2023/9/1221:00PRNUSCuris Announces Date for the 2nd Symposium on IRAK4 in..
2023/9/0621:13PRNUSCuris to Present at Upcoming Healthcare Conferences in..
2023/8/1905:02EDGAR2Form DEF 14A - Other definitive proxy statements
2023/8/0505:09EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/0405:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:02EDGAR2Form 8-K - Current report
2023/8/0405:01PRNUSCuris Provides Second Quarter 2023 Business Update
2023/7/2807:25PRNUSCuris to Release Second Quarter 2023 Financial Results and..
2023/7/0705:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/0622:28EDGAR2Form 8-K - Current report
2023/7/0621:04EDGAR2Form 8-K - Current report
2023/7/0621:01PRNUSFDA Removes Partial Clinical Hold on TakeAim Leukemia Study..
2023/7/0621:00PRNUSCuris Announces $15.1 Million Registered Direct Offering
2023/5/0520:30PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
2023/5/0505:01PRNUSCuris Provides First Quarter 2023 Business Update

最近閲覧した銘柄

Delayed Upgrade Clock